Nuveen’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.2M Sell
537,451
-104,917
-16% -$3.43M 0.01% 1136
2025
Q4
$19.3M Buy
642,368
+76,025
+13% +$2.15M 0.01% 1160
2025
Q3
$14.9M Buy
566,343
+14,449
+3% +$344K ﹤0.01% 1324
2025
Q2
$11.8M Sell
551,894
-500,520
-48% -$11.3M ﹤0.01% 1411
2025
Q1
$33.3M Buy
1,052,414
+505,274
+92% +$10.4M 0.01% 819
2024
Q4
$11.1M Buy
547,140
+15,550
+3% +$321K ﹤0.01% 1541
2024
Q3
$8.93M Buy
+531,590
New +$8.96M ﹤0.01% 1680

Other funds holding GRDN

Nuveen's GRDN Position: Q1 2026 in Review

Nuveen reduced its Guardian Pharmacy Services (GRDN) stake by 16% in Q1 2026, selling an estimated $3.43M and leaving 537,451 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #1136.

Nuveen first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $33.3M in Q1 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Nuveen held 537,451 shares of Guardian Pharmacy Services worth $20.2M as of Q1 2026.
  • Nuveen sold 104,917 Guardian Pharmacy Services shares in Q1 2026, an estimated $3.43M.
  • Guardian Pharmacy Services made up 0.01% of Nuveen's portfolio in Q1 2026, its #1136 holding.
  • Nuveen first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Nuveen's Guardian Pharmacy Services position peaked at $33.3M in Q1 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.